New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.

Autor: Marta Malagón, Sara Ramió-Pujol, Marta Serrano, Joan Amoedo, Lia Oliver, Anna Bahí, Josep Oriol Miquel-Cusachs, Manel Ramirez, Xavier Queralt-Moles, Pau Gilabert, Joan Saló, Jordi Guardiola, Virginia Piñol, Mariona Serra-Pagès, Antoni Castells, Xavier Aldeguer, L Jesús Garcia-Gil

Publikováno v: PLoS ONE, Vol 15, Iss 12, p e0243158 (2020)

Guidelines recommend routine screening for colorectal cancer (CRC) in asymptomatic adults starting at age 50. The most extensively used noninvasive test for CRC screening is the fecal immunochemical test (FIT), which has an overall sensitivity for CR

Externí odkaz: https://doaj.org/article/44934b6419c64f68b0a27a8895c1930d

ZDHHC15 as a candidate gene for autism spectrum disorder

Autor: Dolors Casellas‐Vidal, Irene Mademont‐Soler, Joana Sánchez, Alberto Plaja, Neus Castells, Maria Camós, Javier Nieto‐Moragas, Maria del Mar García, Celia Rodriguez‐Solera, Helena Rivera, Joan Brunet, Sara Álvarez, Josep Perapoch, Xavier Queralt, María Obón

Publikováno v: American Journal of Medical Genetics Part A. 191:941-947

The phenotypic repercussion of ZDHHC15 haploinsufficiency is not well-known. This gene was initially suggested as a candidate for X-linked mental retardation, but such an association was later questioned. We studied a multiplex family with three memb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7efffabd9ba05e62a39970c7dfb4e0e5
https://doi.org/10.1002/ajmg.a.63099

Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?

Autor: Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, Agustín Pappolla, Paula Tagliani, Samuel López-Maza, Simón Cárdenas-Robledo, Juliana Esperalba, Candela Fernández-Naval, Monica Martínez-Gallo, Mireia Castillo, Mercè Bonastre, Mireia Resina-Salles, Jordina Bertran, Marta Rodriguez-Barranco, Pere Carbonell-Mirabent, Marina Gonzalez, Miguel Merchan, Ana Quiroga-Varela, Albert Miguela, Imma Gómez, Gary Álvarez, René Robles, Dúnia Perez del Campo, Xavier Queralt, Maria José Soler, Irene Agraz, Fernando Martinez-Valle, Breogán Rodríguez-Acevedo, Luciana Midaglia, Ángela Vidal-Jordana, Álvaro Cobo-Calvo, Carmen Tur, Ingrid Galan, Joaquín Castillo, Jordi Río, Carmen Espejo, Manuel Comabella, Carlos Nos, Jaume Sastre-Garriga, Lluís Ramió-Torrentà, Mar Tintoré, Xavier Montalban

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England). 28(7)

Background: The effect of disease-modifying therapies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response is unclear. Objectives: We aim to determine the immunological responses to SARS-CoV-2 in multiple sclerosis (MS) an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b98b3d06c743d1ece8e40e4f5a19bd4
https://pubmed.ncbi.nlm.nih.gov/35475363

Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin

Autor: Xavier Queralt, Maria Buxó, María José Ferri, Isabel Serra, Carme López, Mercè Alsius, D. Acero

Publikováno v: Gastroenterología y Hepatología (English Edition). 42:82-89

The cytoplasmic rods-rings (RR) pattern is found in hepatitis C (HCV) patients treated with interferon-ribavirin when studied with ANA-IIF. Ribavirin aggregates/induces antigenic changes in IMPDH-2, an enzyme necessary for ribavirin action.Prospectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d46b8626ed5687ba0119fa5319f694c
https://doi.org/10.1016/j.gastre.2019.02.004

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population

Autor: J O Miquel-Cusachs, Antoni Castells, Xavier Queralt-Moles, Anna Bahí, Lia Oliver, Pau Gilabert, Jordi Guardiola, Virginia Piñol, Manel Ramirez, L. Jesús Garcia-Gil, Joan Saló, Xavier Aldeguer, Mariona Serra-Pagès, Marta Serrano, Joan Amoedo, Marta Malagón, Sara Ramió-Pujol

Publikováno v: PLoS One, 2020, vol. 15, núm. 12, p. e0243158
Articles publicats (D-B)
Malagón Rodríguez, Marta Ramió Pujol, Sara Serrano, Marta Amoedo, Joan Oliver, Lia Bahí, Anna Miquel Cusachs, Josep Oriol Ramírez, Manel Queralt Moles, Xavier Gilabert, Pau Saló, Joan Guardiola, Jordi Piñol Sánchez, Virgínia Serra Pagès, Mariona Castells, Antoni Aldeguer i Manté, Xavier Garcia-Gil, L. J. 2020 New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population PLoS One 15 12 e0243158
DUGiDocs – Universitat de Girona
instname
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE, Vol 15, Iss 12, p e0243158 (2020)
PLoS ONE

Guidelines recommend routine screening for colorectal cancer (CRC) in asymptomatic adults starting at age 50. The most extensively used noninvasive test for CRC screening is the fecal immunochemical test (FIT), which has an overall sensitivity for CR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7270f9f289880df742de405b2cc8c932
http://hdl.handle.net/10256/18762